Results 11 to 20 of about 7,470 (208)

Improvement in delirium and visuospatial function after rivastigmine in antimuscarinic toxicity: a case report

open access: yesToxicology Communications, 2023
Treatment of antimuscarinic toxicity has become more difficult in the United States due to an ongoing national shortage of physostigmine. Rivastigmine has emerged as an alternative, off-label therapy due to its similar mechanism of action as a reversible,
Matthew S. Correia   +1 more
doaj   +2 more sources

Cost-effectiveness of solifenacin compared with oral antimuscarinic agents for the treatment of patients with overactive bladder in the UK

open access: yesJournal of Market Access & Health Policy, 2018
Objective: To evaluate the cost-effectiveness of solifenacin 5 mg/day versus other oral antimuscarinic agents used for overactive bladder (OAB) from a UK National Health Service (NHS) perspective.
Zalmai Hakimi   +6 more
doaj   +2 more sources

Are Antimuscarinic Drugs Effective Against Urinary Frequency Mediated by Atropine-Resistant Contractions?

open access: yesJournal of Pharmacological Sciences, 2011
In the disease states of urinary frequency and urgency, atropine-resistant contractions are known to be involved, in addition to contractions mediated by cholinergic nerves.
Fukumitsu Sakakibara   +2 more
doaj   +2 more sources

β3-Adrenoceptor Agonists for Neurogenic Lower Urinary Tract Dysfunction: Evidence and Clinical Rationale for First-Line Therapy. [PDF]

open access: yesNeurourol Urodyn
ABSTRACT Aims To summarize current evidence on β3‐adrenoceptor agonists for managing neurogenic lower urinary tract dysfunction (NLUTD), focusing on their efficacy, safety, and clinical role in optimizing bladder storage and protecting upper tracts. Methods Evidence from randomized controlled trials, meta‐analyses, and observational studies in spinal ...
Fishberg SE, Matta R.
europepmc   +2 more sources

Acute Encephalopathy in a Patient With Chronic Isotretinoin Exposure and Frequent Rizatriptan Use: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Acute encephalopathy in patients with prolonged isotretinoin exposure should prompt careful assessment of undisclosed or non‐prescribed medication use. This case suggests a possible association between high cumulative isotretinoin exposure, frequent daily rizatriptan use, and acute encephalopathy, but does not establish a definitive drug–drug ...
Roshanzamiri S   +5 more
europepmc   +2 more sources

Antimuscarinic-Induced Convulsions in Fasted Rats after Food Intake: EEG Patterns of Fasting, Scopolamine Treatment, and Convulsions

open access: yesArchives of Epilepsy, 2022
Objective:Antimuscarinic treatment in fasted mice and rats causes clonic convulsion soon after food intake. This study was designed to evaluate the electrophysiological markers of these convulsions and fasting in electrocorticograms in rats.Methods:Male ...
Aslı Zengin Türkmen   +5 more
doaj   +1 more source

Use of Antimuscarinics in the Elderly

open access: yesThe Scientific World JOURNAL, 2009
Overactive bladder (OAB) is a common, costly, and treatable condition in older persons. There is a wide array of available antimuscarinics for the treatment of these conditions; however, their side effect profile and the limited number of studies that evaluate their effect in the elderly curb their use.
Bhavin Patel   +2 more
openaire   +4 more sources

Efficacy and safety of dose escalation in male patients with overactive bladder showing poor efficacy after low-dose antimuscarinic treatment: A retrospective multicenter study [PDF]

open access: yesInvestigative and Clinical Urology, 2020
Purpose: To analyze the efficacy and safety of standard-dose antimuscarinic treatment on male patients with overactive bladder (OAB) symptoms showing poor efficacy after low-dose antimuscarinics.
Myungsun Shim   +11 more
doaj   +1 more source

Urinary Nerve Growth Factor as a Potential Biomarker of Treatment Outcomes in Overactive Bladder Patients [PDF]

open access: yesInternational Neurourology Journal, 2017
Purpose The aim of this study was to investigate urinary nerve growth factor (NGF) as a biomarker of treatment efficacy and recurrence in overactive bladder (OAB) patients.
Yoon Seok Suh   +6 more
doaj   +1 more source

Literature Review: Efektivitas, Keamanan, dan Biaya Terapi Imidafenacin untuk Pasien Overactive Bladder

open access: yesJurnal Kesehatan, 2020
Imidafenacin is a new antimuscarinic agent in Indonesia that was recently approved in 2019 to treat overactive bladder (OAB) symptoms, including urinary incontinence, urinary frequency, and urinary urgency.
Steven Victoria Halim
doaj   +1 more source

Home - About - Disclaimer - Privacy